These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14604548)

  • 41. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
    Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
    Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
    Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
    Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of the early lymphocyte activation antigen CD69, a C-type lectin, is regulated by mRNA degradation associated with AU-rich sequence motifs.
    Santis AG; López-Cabrera M; Sánchez-Madrid F; Proudfoot N
    Eur J Immunol; 1995 Aug; 25(8):2142-6. PubMed ID: 7664776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.
    Pisegna S; Zingoni A; Pirozzi G; Cinque B; Cifone MG; Morrone S; Piccoli M; Frati L; Palmieri G; Santoni A
    J Immunol; 2002 Jul; 169(1):68-74. PubMed ID: 12077230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
    Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
    Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
    Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
    Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression.
    Risso A; Smilovich D; Capra MC; Baldissarro I; Yan G; Bargellesi A; Cosulich ME
    J Immunol; 1991 Jun; 146(12):4105-14. PubMed ID: 1710239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential expression and regulation of CD6 on T-cell subsets revealed by monoclonal antibody (MAb) CH11.
    Bank I; Dardik R; Levy V; Goldstein I; Shoham J
    Hybridoma; 2001 Apr; 20(2):75-84. PubMed ID: 11394533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD53, a thymocyte selection marker whose induction requires a lower affinity TCR-MHC interaction than CD69, but is up-regulated with slower kinetics.
    Puls KL; Hogquist KA; Reilly N; Wright MD
    Int Immunol; 2002 Mar; 14(3):249-58. PubMed ID: 11867561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells.
    Testi R; D'Ambrosio D; De Maria R; Santoni A
    Immunol Today; 1994 Oct; 15(10):479-83. PubMed ID: 7945773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis.
    Liappas G; González-Mateo GT; Sánchez-Díaz R; Lazcano JJ; Lasarte S; Matesanz-Marín A; Zur R; Ferrantelli E; Ramírez LG; Aguilera A; Fernández-Ruiz E; Beelen RH; Selgas R; Sánchez-Madrid F; Martín P; López-Cabrera M
    J Am Soc Nephrol; 2016 Dec; 27(12):3561-3576. PubMed ID: 27151919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
    Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
    Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells.
    Mita Y; Kimura MY; Hayashizaki K; Koyama-Nasu R; Ito T; Motohashi S; Okamoto Y; Nakayama T
    Int Immunol; 2018 Nov; 30(12):559-567. PubMed ID: 30085193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69.
    Sánchez-Mateos P; Sánchez-Madrid F
    Eur J Immunol; 1991 Oct; 21(10):2317-25. PubMed ID: 1717281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The activation antigen CD69.
    Ziegler SF; Ramsdell F; Alderson MR
    Stem Cells; 1994 Sep; 12(5):456-65. PubMed ID: 7804122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amelioration of concanavalin A-induced autoimmune hepatitis by magnesium isoglycyrrhizinate through inhibition of CD4(+)CD25(-)CD69(+) subset proliferation.
    Yang Q; Wang J; Liu R; Wang Z; Li Y; Zhang Y; Hao X; Huang Y; Xie W; Wei H
    Drug Des Devel Ther; 2016; 10():443-53. PubMed ID: 26869766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: a three-colour cytometric analysis.
    Afeltra A; Galeazzi M; Sebastiani GD; Ferri GM; Caccavo D; Addessi MA; Marcolongo R; Bonomo L
    Int J Exp Pathol; 1997 Oct; 78(5):331-6. PubMed ID: 9462230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.